Other Events in the Series
Hanson Wade is committed to delivering an exclusive platform to unite the community and explore the key challenges to your industry, guided by global thought leaders in each discipline.
Dedicated to the development of safe, clinically effective and globally accessible therapies, the series is an unrivalled opportunity to gather with experts in your discipline.
March 1-3, 2022 | Boston, MA*
"Advance More Innovative, Targeted & Clinically Successful Therapeutics for Rare and Diabetic Kidney Diseases"
* 10% Discount available for HFpEF attendees - Claim here
April 25 - 27, 2022 | Boston, MA
"Progress Combination Therapies, Outline Clinical Endpoints & Understand the Immunology Perspective to Achieve Functional Cures for Chronic Hepatitis B"
December 2022
"Deepening Understanding of Early, Translational & Late-Stage Clinical Science to Support NASH Candidate Entry to Market"
November 2022
www.rare-kidney-drug-development.com
"Elucidate Genetic Targets, Establish Novel Biomarkers, & Confidently Recruit Patients & Execute Clinical Trials in Orphan Disease Populations"